Co-morbidities are common and rising among people with HIV in the US
French study reveals the growing complexity of medical needs as people with HIV age
Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk
Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation
Promising trends continue in UK diagnosis and treatment rates
Managing non-communicable diseases among people living with HIV
Depression increases risk of heart attack for adults with HIV
START analysis looks at who benefits most from immediate HIV treatment
